Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Identification of Microbes in Healthy… >

Identification of Microbes in Healthy Lungs Sheds Light on Cystic Fibrosis

Published: September 28, 2012.
Released by Stanford University Medical Center  

STANFORD, Calif. — Healthy people's lungs are home to a diverse community of microbes that differs markedly from the bacteria found in the lungs of cystic fibrosis patients. That's the result of new research from Stanford University and Lucile Packard Children's Hospital, which has wide implications for treatment of cystic fibrosis and other lung diseases.

"The lung is not a sterile organ," said David Cornfield, MD, an author of the new study, which will be published Sept. 26 in Science Translational Medicine. Although decades of received scientific wisdom said healthy lungs lacked resident microbes, scientists had begun questioning that notion. "This research confirmed a long-held suspicion that a forest of microbes exists in both healthy and diseased lungs," said Cornfield, a pulmonologist at Packard Children's and a professor of pediatrics in pulmonary medicine at the School of Medicine. "More surprising, our data presents a suggestion that the lung flora provides microbial homeostasis that might function to preserve health."

Healthy lungs' microbes have been overlooked in part because past research has focused heavily on lung diseases, Cornfield said. Another flaw in prior studies was a bias toward looking for micro-organisms that could be grown in labs. Many of the types of microbes that the Stanford researchers found in healthy lungs have never been cultured in a laboratory.

In contrast, a large body of research had previously shown chronic microbial colonization in the lungs of people with cystic fibrosis, a genetic disease characterized by serious, progressive lung problems and death from respiratory failure. For instance, CF patients are vulnerable to chronic infection with the bacteria Pseudomonas aeruginosa, which can cause pneumonia.

The new study used sputum samples from 16 CF patients and nine healthy control patients. The scientists also analyzed lung tissue samples from seven patients' explanted lungs, the organs removed when the patients received lung transplants. (Three lung-transplant recipients had CF; four had other lung diseases.) The researchers extracted DNA from the sputum and tissue, and selectively copied genes coding for the 16S ribosomal gene sequences, which are found only in bacteria. The resulting genetic material was measured to determine which phyla, or families, of bacteria it came from and the relative contributions of each bacterial phylum to the total bacterial population in the lungs.

Several differences emerged between CF patients and healthy people's communities of lung bacteria. In general, healthy individuals had more diversity among their lung bacteria. Different bacterial phyla predominated in the two groups: members of the Bacteroidetes and Fusobacteria phyla were much more prominent in healthy individuals, whereas CF patients had a larger percentage of Actinobacteria. Also, healthy people had a larger proportion of bacteria that had never been grown in a lab.

"I think the tendency toward decreased diversity can be metaphorically viewed as the same phenomenon that might happen in a rainforest," Cornfield said. "When the ecosystem of a rainforest is disturbed and one organism predominates, it undermines a carefully constructed balance and causes disturbances in overall ecosystem. I think it's reasonable to assume something similar could happen in the lung microbiome, where pathogenic bacteria may out-compete organisms that may play a salutary, health-affirming role."

The results open many questions for future research. No one has ever tested the idea that certain microbes benefit lung health, for instance. "We may need to consider strategies that allow favorable microbes to exist while eradicating disease-causing species," Cornfield said. "That paradigm, if it's true, would really turn the care of patients with pneumonia and other lower-airway diseases on its head." Future research might test whether CF or pneumonia patients could benefit from doses of probiotic bacteria to their lungs, he said.

In addition, no one is sure how the antibiotics often given to CF patients change the microbes in their lungs.

"The marked differences in composition and diversity of microbial communities from adults with cystic fibrosis and normal controls are intriguing," said Thomas Ferkol, MD, director of allergy, immunology and pulmonary medicine at the Washington University School of Medicine in St. Louis. "The question that remains to be answered is whether these differences are directly related to the underlying lung disease or simply a consequence of frequent antibiotic use, which has been shown to change microbiota of the upper airways." Ferkol was not involved in the research.

More questions arise from the fact that bacterial profiles varied within the group of CF patients. CF patients differ widely in their disease progression, even when they have the same disease-causing gene mutations. It is possible that patients' lung function may be linked to the bacteria present in their lungs. The research team now plans to study whether individual patients' bacterial profiles can be used to predict their clinical condition.




The above story is based on materials provided by Stanford University Medical Center.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Mice 
10/15/14 
★★★★ 
Researchers Look to Exploit Females' Natural Resistance to Infection
Researchers have linked increased resistance to bacterial pneumonia in female mice to an enzyme activated by the female sex …
Cells 
3/26/12 
Using Viruses to Beat Superbugs
Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial …
Scvs 
1/26/11 
Research Shows How Pathogenic Bacteria Hide Inside Host Cells
A new study into Staphylococcus aureus, the bacterium which is responsible for severe chronic infections worldwide, reveals how bacteria …
Genes 
10/26/12 
★ 

Scientists Step Up Hunt for Bacterial Genes Tied to Lyme Disease
Killing 
7/4/12 
Cystic Fibrosis Makes Airways More Acidic, Reduces Bacterial Killing
The human airway is a pretty inhospitable place for microbes. There are numerous immune defense mechanisms poised to kill …
Rock 
8/6/14 
Discovery Yields Master Regulator of Toxin Production in Staph Infections
St. Jude Children's Research Hospital scientists have discovered an enzyme that regulates production of the toxins that contribute to …
Coxiella 
5/30/12 
The Effect of Treatment with Antibiotics And Vaccination Against Q Fever in Sheep
Scientists at Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, have evaluated the effect of treatment with antibiotics …
Effects 
4/26/12 
Invisible Helpers: How Probiotic Bacteria Protect Against Inflammatory Bowel Diseases
Yoghurt has been valued for centuries for its health-promoting effects. These effects are thought to be mediated by the …
Species 
3/18/15 
New Molecular Tool Assesses Vaginal Microbiome Health, Diagnoses Infections - Fast
A new microarray-based tool, called VaginArray, offers the potential to provide a fast, reliable and low-cost assessment of vaginal …
More » 
 
© Newsline Foundation  |  About  |  Privacy Policy  |  Feedback  |  Mobile